Progyny/$PGNY
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Progyny
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Ticker
$PGNY
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
678
ISIN
US74340E1038
Website
Progyny Metrics
BasicAdvanced
$1.8B
37.88
$0.57
1.38
-
Price and volume
Market cap
$1.8B
Beta
1.38
52-week high
$30.42
52-week low
$13.39
Average daily volume
1M
Financial strength
Current ratio
2.394
Quick ratio
2.344
Long term debt to equity
5.565
Total debt to equity
5.565
Profitability
EBITDA (TTM)
76.669
Gross margin (TTM)
21.99%
Net profit margin (TTM)
4.33%
Operating margin (TTM)
6.03%
Effective tax rate (TTM)
39.81%
Revenue per employee (TTM)
$1,790,000
Management effectiveness
Return on assets (TTM)
5.99%
Return on equity (TTM)
10.11%
Valuation
Price to earnings (TTM)
37.881
Price to revenue (TTM)
1.57
Price to book
3.91
Price to tangible book (TTM)
4.14
Price to free cash flow (TTM)
9.726
Free cash flow yield (TTM)
10.28%
Free cash flow per share (TTM)
220.64%
Growth
Revenue change (TTM)
9.47%
Earnings per share change (TTM)
-7.16%
3-year revenue growth (CAGR)
30.12%
3-year earnings per share growth (CAGR)
0.36%
What the Analysts think about Progyny
Analyst ratings (Buy, Hold, Sell) for Progyny stock.
Bulls say / Bears say
Progyny's revenue increased by 7.22% in 2024, reaching $1.17 billion, indicating strong demand for its fertility benefits services. (stockanalysis.com)
The company maintains a robust liquidity position with $227.95 million in cash and marketable securities, providing financial flexibility for future growth initiatives. (tipranks.com)
Progyny's operating income has increased by 27% year-over-year, reflecting improved operational efficiency and profitability. (fullratio.com)
A report by Spruce Point Capital Management highlights concerns about Progyny's competitive advantages, suggesting that the fertility benefits marketplace is becoming increasingly commoditized and crowded. (businesswire.com)
Progyny's net income decreased by 12.41% in 2024, indicating potential challenges in maintaining profitability. (stockanalysis.com)
The company's return on equity (ROE) decreased to 0.02 in Q3 2024 from 0.04 in Q2 2024, suggesting a decline in the company's ability to generate returns for shareholders. (siriusinvestors.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.
Progyny Financial Performance
Revenues and expenses
Progyny Earnings Performance
Company profitability
Progyny News
AllArticlesVideos
Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women's Health
GlobeNewsWire·1 week ago
Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution
GlobeNewsWire·3 weeks ago
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Progyny stock?
Progyny (PGNY) has a market cap of $1.8B as of July 04, 2025.
What is the P/E ratio for Progyny stock?
The price to earnings (P/E) ratio for Progyny (PGNY) stock is 37.88 as of July 04, 2025.
Does Progyny stock pay dividends?
No, Progyny (PGNY) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next Progyny dividend payment date?
Progyny (PGNY) stock does not pay dividends to its shareholders.
What is the beta indicator for Progyny?
Progyny (PGNY) has a beta rating of 1.38. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.